<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02116257</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0702</org_study_id>
    <nct_id>NCT02116257</nct_id>
  </id_info>
  <brief_title>The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      While Patient-controlled analgesia (PCA) has the advantage of effectively reducing the degree
      of postoperative pain, it can also affect the patient's outcome by several adverse effects
      such as postoperative nausea and vomiting (PONV). Especially for high risk group of patients
      for PONV, the ideal regimen for sufficient analgesia with minimal adverse effect needs to be
      sought. Propacetamol is known for its effective, rapid analgesia, opioid-sparing effect, and
      is used widely for post operative pain management. This study aims to see the opioid-sparing
      effect and the degree of PONV when propacetamol is added to PCA for high risk PONV patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of PONV</measure>
    <time_frame>from immediate postop to 24 hours after the surgery</time_frame>
    <description>Incidence of postoperative nausea, vomiting - Number of events</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>PONV</condition>
  <condition>Propacetamol</condition>
  <arm_group>
    <arm_group_label>Propacetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PCA regimen</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>routine PCA drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propacetamol</intervention_name>
    <description>total 4g of Propacetamol added to patient's PCA regimen</description>
    <arm_group_label>Propacetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PCA regimen</intervention_name>
    <arm_group_label>PCA regimen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients scheduled for either 1-2 level spine fusion or laminectomy

          2. ASA (American Society of Anesthesiology) physical status 1 or 2

          3. Non-smoking female patients, between the age 20 and 65

        Exclusion Criteria:

          1. Administration of any anti-emetic agents within 24 hours prior to surgery

          2. Administration of any opioid agents within 7 days prior to surgery

          3. Regular administration of any steroid agents

          4. Drug or alcohol-abuser

          5. Patients with bowel movement disorder, liver or renal impairment, insulin-dependent
             diabetes. Patients who are pregnant, illiterate, or foreign.

          6. Patients administered to Intensive Care Unit after surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2014</study_first_submitted>
  <study_first_submitted_qc>April 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2014</study_first_posted>
  <last_update_submitted>June 23, 2015</last_update_submitted>
  <last_update_submitted_qc>June 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nausea</keyword>
  <keyword>Vomiting</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propacetamol</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

